Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03093636 · ClinicalTrials.gov registry record · NA
Efficacy of inControl Advice: A Decision Support System (DSS) for Diabetes
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT03093636: Completed NA study, sponsored by University of Virginia.
NCT03093636 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03093636, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to reduce the frequency of hypoglycemia and severe hypoglycemic events in subjects who use insulin pens to treat their Type 1 Diabetes Mellitus (T1DM). Hypoglycemia is the number one fear of many individuals and families with someone who has type 1 diabetes, and this fear often prevents optimal glycemic control. It is expected that this protocol will yield increased knowledge about using a decision support system to help control the glucose level.
Primary Outcome
The primary efficacy outcome is increased % time within target range defined as CGM readings of 70-180 mg/dL.
Interventions
- DEVICE Continuous Glucose Monitor (CGM)+Decision Support System (DSS)
- OTHER Continuous Glucose Monitor (CGM) alone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2017-04-17 |
| Est. Completion | 2019-03-19 |
| Phase | NA |
What the finished NCT03093636 record still lists
NCT03093636 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Continuous Glucose Monitor (CGM)+Decision Support System (DSS) is the first listed.
NCT03093636 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03093636 about?
NCT03093636 is a clinical study titled "Efficacy of inControl Advice: A Decision Support System (DSS) for Diabetes". The purpose of this study is to reduce the frequency of hypoglycemia and severe hypoglycemic events in subjects who use insulin pens to treat their Type 1 Diabetes Mellitus (T1DM). Hypoglycemia is the number one fear of many individuals and families with someone who has type 1 diabetes, and this fea...
What is the current status of trial NCT03093636?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2017-04-17. Estimated completion is 2019-03-19.
What interventions are being tested in trial NCT03093636?
The interventions under investigation include: Continuous Glucose Monitor (CGM)+Decision Support System (DSS) (DEVICE), Continuous Glucose Monitor (CGM) alone (OTHER).
Who is sponsoring clinical trial NCT03093636?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03093636's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI